Research and Markets: Global Infectious Disease Treatment Market 2014-2018: Key Vendors Are F. Hoffmann-La Roche, Gilead Sciences, GSK, J&J Merck & Pfizer
Appears to be priced in, for now.
A look at ownership data can provide a more detailed look at what mutual funds and institutional players are buying and selling.
When it comes to expenses, CEFs are quite different than open-end mutual funds.
Despite the market's wild ride, most CEFs closed the year with positive share price and NAV returns.
We saw some big trend reversals in 2012's fund launches.
Morningstar's Steve Pikelny discusses his closed-end fund ideas for international fixed-income and equity exposure and the advantages for using CEFs in these areas.
Plus, Wasatch to launch India fund , and more.